Dr Helen Do is a consultant ophthalmic surgeon specialising in medical retina, cataract surgery and comprehensive ophthalmic care. She is a Staff Specialist at Westmead Hospital and Head of Auburn Cataract Services, where she is actively involved in clinical leadership and the training of ophthalmology registrars. She is also a Clinical Lecturer at the University of Sydney and Macquarie University.

​

Dr Do has particular expertise in the treatment of retinal and macular conditions, including age-related macular degeneration, diabetic retinopathy, retinal vein occlusions and central serous chorioretinopathy. She provides intravitreal injection therapy and retinal laser treatment, with a strong emphasis on patient comfort, clear communication and ensuring that each patient receives the most appropriate treatment for their individual condition.

​

In addition to her retinal practice, Dr Do performs cataract surgery including laser assisted cataract surgery,  and provides medical and laser treatment for glaucoma. She also manages acute and general ophthalmic conditions, offers comprehensive eye assessments and second opinions, and is committed to thoughtful, patient-focused care.

​

Dr Do graduated in Medicine from the University of New South Wales with First Class Honours. She subsequently completed a Master of Medicine in Ophthalmic Science at the University of Sydney, writing her treatise on retinal vein occlusions. She undertook specialist ophthalmology training through the Sydney Eye Hospital network, including placements at Royal Prince Alfred Hospital and Liverpool Hospital, as well as ophthalmology outreach work in rural Northern Territory through Royal Darwin Hospital.

​

Following specialist training, Dr Do completed further fellowship training in complex cataract surgery and acute ophthalmology at Concord Hospital, followed by a Medical Retina Fellowship in Sydney.

​

Dr Do has published in peer-reviewed medical journals and remains actively involved in research and clinical trials. Her research interests include new treatments for age related macular degeneration and diabetic retinopathy. She is committed to combining current evidence and advances in ophthalmic treatment with careful communication, personalised management and long-term continuity of care.